Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 655064, an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases - Concepedia

Concepedia

Publication | Open Access

Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 655064, an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases

DOI Full Paper Access

33

Citations

26

References

2017

Year

Fredrik N. Albach, Frank Wagner, Andreas Hüser, Julia Igel, David Joseph, James Hilbert, Corinna Schoelch, Steven J. Padula, Jürgen Steffgen

European Journal of Clinical Pharmacology

Abstract

ClinicalTrials.gov Identifier: NCT01510782.

References

	Year	Citations
The Wellcome Trust Case Control Consortium, U.K. Kaspar Mossman Scientific American Data TrustArtsBusinessLawTrust	2008	2.7K
Monoclonal Antibody Pharmacokinetics and Pharmacodynamics Wenhui Wang, EQ Wang, JP Balthasar Clinical Pharmacology & Therapeutics	2008	937
A short course of BG9588 (anti–CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis Dimitrios T. Boumpas, Richard Furie, Susan Manzi, Arthritis & Rheumatism	2003	609
Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. Erik A. Ranheim, Thomas J. Kipps The Journal of Experimental Medicine Lymphocyte DevelopmentAdaptive Immune SystemImmunologyImmunologic MechanismAntigen Processing	1993	596
ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice. P. S. Bhuiyan, N. N. Rege PubMed	2002	531
Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. Ami Desai‐Mehta, Liwei Lu, Rosalind Ramsey‐Goldman, Journal of Clinical Investigation Active LupusAdaptive Immune SystemImmunologyCd40 LigandT Cells	1996	520
CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. K Karmann, Christopher C.W. Hughes, Jeffrey S. Schechner, Proceedings of the National Academy of Sciences Cell AdhesionImmunologyImmune RegulationPathologyImmunologic Mechanism	1995	478
Agonistic CD40 Antibodies and Cancer Therapy Clinical Cancer Research	2013	407
Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. Douglas Berger, Mary K. Crow Journal of Clinical Investigation ImmunologyPathologyCd40 LigandImmunotherapyImmune Dysregulation	1996	361
CD40 Is Constitutively Expressed on Platelets and Provides a Novel Mechanism for Platelet Activation David Inwald, Alison McDowall, Mark Peters, Circulation Research Platelet DifferentiationImmunologyImmune RegulationBlood CellImmunologic Mechanism	2003	325

Page 1